Arete Wealth Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,127
Closed -$558K 789
2025
Q2
$558K Buy
+2,127
New +$518K 0.04% 378
2023
Q3
Sell
-2,648
Closed -$549K 622
2023
Q2
$549K Sell
2,648
-690
-21% -$134K 0.05% 343
2023
Q1
$658K Sell
3,338
-50
-1% -$10.3K 0.05% 284
2022
Q4
$685K Buy
3,388
+1
+0% +$195 0.06% 267
2022
Q3
$596K Buy
+3,387
New +$693K 0.06% 268

Other funds holding LH

Arete Wealth Advisors's LH Position: Q3 2025 in Review

Arete Wealth Advisors sold out of Labcorp (LH) in Q3 2025, closing a stake of 2,127 shares — an estimated $558K sold.

Arete Wealth Advisors first reported a position in LH in Q3 2022 and held it in 5 quarters. The position peaked at $685K in Q4 2022. 1,010 funds tracked by Wall St. Rank hold LH as of Q3 2025.

  • Arete Wealth Advisors reported no remaining Labcorp position as of Q3 2025 after selling out during the quarter.
  • Arete Wealth Advisors sold 2,127 Labcorp shares in Q3 2025, an estimated $558K.
  • Arete Wealth Advisors first reported a position in Labcorp in Q3 2022 and held it in 5 quarters.
  • Arete Wealth Advisors's Labcorp position peaked at $685K in Q4 2022.
  • 1,010 funds tracked by Wall St. Rank held Labcorp as of Q3 2025.

Based on Arete Wealth Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.